作者
David B Wright, Thomas Trian, Sana Siddiqui, Chris D Pascoe, Oluwaseun O Ojo, Jill R Johnson, Bart GJ Dekkers, Shyamala Dakshinamurti, Rushita Bagchi, Janette K Burgess, Varsha Kanabar
发表日期
2013/2/28
期刊
Pulmonary pharmacology & therapeutics
卷号
26
期号
1
页码范围
95-104
出版商
Academic Press
简介
In asthma, the airway smooth muscle (ASM) cell plays a central role in disease pathogenesis through cellular changes which may impact on its microenvironment and alter ASM response and function. The answer to the long debated question of what makes a ‘healthy’ ASM cell become ‘asthmatic’ still remains speculative. What is known of an ‘asthmatic’ ASM cell, is its ability to contribute to the hallmarks of asthma such as bronchoconstriction (contractile phenotype), inflammation (synthetic phenotype) and ASM hyperplasia (proliferative phenotype). The phenotype of healthy or diseased ASM cells or tissue for the most part is determined by expression of key phenotypic markers. ASM is commonly accepted to have different phenotypes: the contractile (differentiated) state versus the synthetic (dedifferentiated) state (with the capacity to synthesize mediators, proliferate and migrate). There is now accumulating …
引用总数
2014201520162017201820192020202145423212
学术搜索中的文章
DB Wright, T Trian, S Siddiqui, CD Pascoe, OO Ojo… - Pulmonary pharmacology & therapeutics, 2013